We deliver market analysis based on earnings data, institutional activity, and broader economic trends.
BeOne Medicines Ltd. American Depositary Shares (ONC) is trading at $295.27 as of May 1, 2026, posting a single-session gain of 1.54% amid muted overall market action for biopharmaceutical names. This analysis reviews recent market context for the ADS, key technical levels that have shaped recent price action, and potential near-term scenarios for traders and investors to monitor. No recent earnings data is available for ONC at this time, so price movement in recent weeks has been driven largely
What value at risk BeOne (ONC)? (Smart Money Flows) 2026-05-01 - Profitability Factor
ONC - Stock Analysis
4196 Comments
540 Likes
1
Davein
Engaged Reader
2 hours ago
This gave me fake clarity.
👍 159
Reply
2
Wailyn
Insight Reader
5 hours ago
Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed in the market. Our platform provides fundamental analysis, technical indicators, and valuation metrics for comprehensive stock evaluation. Find hidden gems in the market with our comprehensive screening tools and expert guidance for smart stock selection.
👍 108
Reply
3
Meiyah
Loyal User
1 day ago
Wow, did you just level up in real life? 🚀
👍 82
Reply
4
Virginia
Returning User
1 day ago
Anyone else here for the same reason?
👍 254
Reply
5
Taison
Elite Member
2 days ago
Indices are consolidating after recent gains, offering tactical entry points.
👍 74
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.